Catalyst Wire Dossier Catalyst Wire Dossier

COVID-19 vaccine booster (recombinant, inactivated)

· Butantan Institute
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for COVID-19 vaccine booster (recombinant, inactivated), covering 2025-02-06 to 2025-02-06. Get the full timeline:

Most recent: Clinical Trial Update: Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine [Phase 2, Phase 3]

See pricing